Introduction {#sec1}
============

A major issue in stem cell biology concerns understanding the mechanisms controlling the balance between self-renewal and differentiation. *Drosophila* germline stem cells (GSCs) have proven to be an excellent model for studying adult stem cells in vivo ([@bib11]). In the *Drosophila* ovary, two to three GSCs are localized at the anterior of the germarium, the anteriormost region of each ovariole, and give rise to the female germline. The GSCs divide asymmetrically to produce a GSC and a cell that differentiates as a cystoblast. The cystoblast then divides four times to produce a cyst of 16 germline cells.

Translational controls have a central role in the regulation of stem cell biology. The importance of translational regulations has been reported in mouse embryonic stem cells, which display a considerable increase in mRNA levels and translation during their differentiation ([@bib33]). In *Drosophila* GSCs, two major factors for stem cell self-renewal are the translational repressors Nanos (Nos) and Pumilio (Pum) ([@bib13; @bib44]). Females mutant for *nos* and *pum* have empty ovaries due to the loss of GSCs by differentiation. Nos and Pum are thus required in the stem cells to repress their differentiation, indicating that stem cell self-renewal corresponds in part to the repression of the differentiation program ([@bib13; @bib44]). The microRNA (miRNA) pathway also plays an essential role in GSC self-renewal. Mutations in *Dicer-1*, *Argonaute1* (*Ago1*), and *loquacious* result in a phenotype of stem cell loss consistent with the potential role of the miRNA pathway in translational repression of differentiation factors in the GSCs ([@bib18; @bib31; @bib49]).

Bag of marbles (Bam) is the major factor of GSC differentiation ([@bib27; @bib30]). *bam* mutant females have tumorous ovaries full of stem cell-like germ cells, whereas overexpression of *bam* in stem cells leads to their differentiation. *bam* transcription in GSCs is repressed by the short-range bone morphogenetic protein (BMP) signaling that emanates from the niche, the microenvironment provided by somatic cells surrounding the GSCs ([@bib36; @bib48]). Upon division, the daughter cell still in contact with the niche continues to receive the BMP signal and thus remains a stem cell, whereas the daughter cell localized posteriorly expresses *bam* due to the lack of BMP signal and thereby differentiates into a cystoblast ([@bib15; @bib47]). Genetic data suggest that Bam promotes differentiation by relieving the Nos/Pum-dependent translational repression of differentiation factors ([@bib6; @bib41]). Consistent with this, Bam downregulates Nos expression in cystoblasts through the regulation of *nos* mRNA ([@bib22]).

To date, a single mRNA target of Nos/Pum regulation has been identified: the *brain tumor* (*brat*) mRNA, which encodes a Trim-NHL domain-containing protein with a known function in stem cell biology ([@bib15]). Brat is a key differentiation factor in neural stem cells ([@bib2; @bib21]) and was recently shown to be involved in female GSC differentiation by repressing the translation of self-renewal mRNAs, including *Mad*, which encodes a component of BMP signaling ([@bib15]). Mei-P26 is another Trim-NHL protein with an essential function in the ovarian stem cell lineage. It promotes differentiation and restricts proliferation in cyst cells by inhibiting the miRNA pathway through its direct association with Ago1 ([@bib29]). More recently, a distinct role for Mei-P26 in GSC self-renewal was described ([@bib23]). Mei-P26 was found to repress Brat expression in GSCs, thus allowing BMP signaling and Bam repression, which are required for GSC self-renewal. However, Mei-P26 overexpression in GSCs leads to GSC loss, highlighting the importance of the precise regulation of Mei-P26 expression levels for GSC biology ([@bib29]).

The mechanisms of action of Nos and Pum in GSC self-renewal remain unknown. In the embryo, Nos and Pum act by two mechanisms: inhibition of translation initiation ([@bib37]) and recruitment of the CCR4-NOT deadenylation complex ([@bib20]). Direct interactions between Pum and the deadenylation complex are conserved from yeast to human ([@bib14; @bib20]). Interactions between the CCR4-NOT deadenylation complex and Nanos2, a mouse homolog of Nos, have also been reported in mouse gonocytes where Nanos2 represses mRNAs involved in meiosis ([@bib39; @bib40]).

The *Drosophila* CCR4-NOT complex is composed of seven proteins: NOT1--NOT4, CAF40, and two potential deadenylases, CCR4 and CAF1 ([@bib1; @bib42; @bib43]). *Drosophila* CCR4 deadenylase is encoded by the *twin* gene, which is required for early oogenesis. *twin* has a role in the control of germ cell divisions leading to 16-cell cysts, in germ cell survival, and in oocyte specification ([@bib28; @bib50]). Here, we address the molecular mechanisms underlying Nos/Pum translational repression in the GSCs. We find that CCR4 is required for GSC self-renewal and interacts with Nos and Pum for this function. We identify *mei-P26* mRNA as a direct target of the Nos/Pum/CCR4 complex. *mei-P26* is a major target of this complex for GSC self-renewal, as GSC loss in *twin* mutants is rescued by lowering the gene dosage of *mei-P26*. In addition, we show that increased expression of Mei-P26 in *twin* mutant GSCs correlates with longer poly(A) tails of its mRNA. These data reveal that Nos and Pum translational repression in the GSCs depends on deadenylation by the CCR4-NOT complex. They also show that GSC fate requires the precise regulation of Mei-P26 levels and that this fine-tuning is achieved by CCR4-NOT-mediated repression.

Results {#sec2}
=======

Function of CCR4 in GSC Self-Renewal {#sec2.1}
------------------------------------

To address a potential function of CCR4 in GSCs, we first analyzed CCR4 expression in these cells. GSCs were identified by their anterior localization in the germarium and by the presence and anterior localization of a spherical organelle called the spectrosome, visualized using the Hu-li tai-shao marker (Hts/1B1 antibody) ([@bib25]) ([Figure 1](#fig1){ref-type="fig"}A). CCR4 was present in the GSCs as well as in other cells in the germarium ([Figure 1](#fig1){ref-type="fig"}C) where it was mostly cytoplasmic and accumulated in discrete foci, as reported in other cell types in the ovary and embryo ([@bib32; @bib42; @bib50]). CCR4 is encoded by the *twin* gene. CCR4 levels were strongly decreased in a strong hypomorphic allele *twin*^*DG24102*^ (see below) ([Figure 1](#fig1){ref-type="fig"}D).

We next analyzed GSC self-renewal in *twin* mutant ovaries using three alleles: *twin*^*8115*^, which we previously characterized as a strong hypomorphic allele ([@bib50]); *twin*^*DG24102*^ (FlyBase); and *twin*^*41*^, obtained after mobilization of the hybrid *P-Hobo*-element inserted into *twin*^*DG24102*^ ([Figure 1](#fig1){ref-type="fig"}B). *twin* mRNA levels quantified by RT-PCR and quantitative RT-PCR (qRT-PCR) were strongly reduced in the ovaries of *twin*^*DG24102*^ and *twin*^*41*^ mutants, indicating that they are strong hypomorphic alleles ([Figure S1](#app2){ref-type="sec"} available online). Ovaries from different allelic combinations were dissected from 3-, 7-, 14-, and 21-day-old females. All germ cells were rapidly lost in *twin* mutant ovaries ([Figures 1](#fig1){ref-type="fig"}E--1G). Quantification of germaria containing GSCs at the four time points showed that 100% of germaria were devoid of GSCs in 7-day-old females hemizygous for all three *twin* alleles over *Df(3R)Exel6198* ([Figure 1](#fig1){ref-type="fig"}H). GSC loss was slightly slower in *twin*^*DG24102*^ homozygous females, consistent with the fact that this is not a null allele ([Figure 1](#fig1){ref-type="fig"}H). These results show that CCR4 is required for GSC self-renewal.

CCR4 Is Required in the GSCs for Their Self-Renewal {#sec2.2}
---------------------------------------------------

We used clonal analysis to determine if CCR4 was required intrinsically in the GSCs for their self-renewal. FLP-mediated FRT recombination was used to generate wild-type or *twin* mutant clonal GSCs that were analyzed at four time points after clone induction. Clonal GSCs were identified by the lack of GFP. In the wild-type, the percentage of germaria with at least one clonal GSC decreased from 31% 3 days after clone induction to 24% 21 days after clone induction, reflecting GSC turnover ([@bib18]) ([Figures 2](#fig2){ref-type="fig"}A and 2B). In *twin*^*8115*^ and *twin*^*DG24102*^, the percentage of germaria with one clonal GSC was similar to wild-type 3 days after clone induction (34% and 31%) but strongly decreased at later time points, with only 5% and 3% of germaria containing a clonal GSC 21 days after clone induction, respectively ([Figures 2](#fig2){ref-type="fig"}A and 2B). This indicated that *twin* mutant GSCs were rapidly lost. This loss was more rapid in *twin*^*DG24102*^ mutant than in *twin*^*8115*^, indicating that *twin*^*DG24102*^ is a stronger allele.

We determined the division rate of *twin*^*8115*^ and *twin*^*DG24102*^ GSCs by counting the number of cysts produced by a clonal marked mutant GSC and dividing it by the number of cysts produced by a wild-type unmarked GSC in the same germarium ([@bib18]). The division rate of wild-type GSCs (*FRT82B* chromosome) was close to 1 (0.93, n = 89), while those of *twin*^*8115*^ and *twin*^*DG24102*^ GSCs were 0.44 (n = 37) and 0.50 (n = 33), respectively, indicating that division in *twin* mutant GSCs is slower than in wild-type.

The loss of *twin* mutant GSCs could result either from apoptosis or differentiation. Clonal *twin* mutant GSCs were able to give rise to differentiated cysts identified by a branched fusome ([Figure 2](#fig2){ref-type="fig"}A), indicating that these mutant GSCs can differentiate. Apoptosis was recorded using activated caspase-3 antibody. The *twin* mutant clonal GSCs were not stained with this antibody (n = 35) ([Figures S2](#app2){ref-type="sec"}A--S2C), thus ruling out their potential death by apoptosis.

As independent evidence in favor of the cell-autonomous requirement of CCR4 for GSC self-renewal, we rescued the *twin*^*DG24102*^ phenotype of GSC loss by expressing CCR4 in the GSCs. We used the *UAS/Gal4* system to express *CCR4-hemagglutinin* (*CCR4-HA*) specifically in the germ cells with the *nos-Gal4* driver. This led to a nearly complete rescue of the *twin*^*DG24102*^ GSC loss phenotype ([Figures 2](#fig2){ref-type="fig"}C--2F).

In the CCR4-NOT complex, both CCR4 and CAF1 are potential deadenylases, and CAF1 has been reported to be the major deadenylase in *Drosophila* S2 cells, with CCR4 acting as a structural subunit in the complex ([@bib43]). To determine whether the deadenylase activity of CCR4 is required for GSC self-renewal, we generated the CCR4mut-Flag transgene, in which CCR4 has a double point mutation inactivating the deadenylase activity ([@bib43]). When expressed with *nos-Gal4*, this deadenylase-dead CCR4 was able to partially rescue the *twin*^*DG24102*^ phenotype of GSC loss, with 59.5% of germaria containing GSCs in 21-day-old females ([Figures 2](#fig2){ref-type="fig"}F and [S2](#app2){ref-type="sec"}D). This indicated that the deadenylase activity of CCR4 could be compensated to some extent for GSC self-renewal. This could result from CAF1 acting as a deadenylase in the GSCs, as in S2 cells, and/or from an additional role of the CCR4-NOT complex in translational repression, independently of deadenylation, as proposed in other systems ([@bib5; @bib9]).

To address whether CCR4 acts in the GSCs as part of the CCR4-NOT complex, we knocked down NOT1, the key structural subunit of the complex, using RNAi in the germ cells. This led to a strong phenotype of lack of GSCs and germ cells ([Figure S2](#app2){ref-type="sec"}E). In addition, CCR4 was found in complex with NOT1 and CAF1 in GSC-like cells, using coimmunoprecipitation (co-IP) experiments on *bam*^*Δ86*^ mutant ovaries, which contain only undifferentiated precystoblasts ([Figure S2](#app2){ref-type="sec"}F).

Taken together, these results show that CCR4, most likely as part of the CCR4-NOT complex, is required intrinsically in the GSCs to control their division rate and for their self-renewal. They also show that *twin* mutant GSCs are not maintained because they differentiate.

CCR4 Functions Together with Pum and Nos {#sec2.3}
----------------------------------------

To genetically determine if *twin* could act together with *nos* and *pum*, we first tested whether the GSC loss phenotype in the hypomorphic *twin*^*DG24102*^ allele could be increased by reducing the gene dosage of *pum* or *nos*. GSC loss in *twin*^*DG24102*^ was accelerated in the presence of both heterozygous *pum*^*MSC*^ or *nos*^*18*^ mutations ([Figure 3](#fig3){ref-type="fig"}A). This is consistent with a role for *twin* and *pum*, and *twin* and *nos*, together in the same pathway.

We analyzed intracellular colocalization in GSCs between Pum or Nos and CCR4 using CCR4-HA. Pum, Nos, and CCR4-HA were present diffusely in the cytoplasm and accumulated in cytoplasmic foci. Colocalization occurred mostly in diffusely distributed pools of proteins ([Figures S3](#app2){ref-type="sec"}A--S3D), consistent with the hypothesis that deadenylation takes place outside foci ([@bib1]).

We addressed whether CCR4, Pum, and Nos form a complex in GSC-like cells using co-IP experiments in *bam*^*Δ86*^ mutant ovaries. The CCR4-HA protein was able to coprecipitate both Pum and Nos in the absence of RNase ([Figure 3](#fig3){ref-type="fig"}B). Both co-IPs still occurred but were decreased in the presence of RNase. In the reverse experiment, Pum was able to coprecipitate Nos and CCR4. The presence of RNase decreased CCR4 co-IP and abolished that of Nos ([Figures 3](#fig3){ref-type="fig"}C and [S3](#app2){ref-type="sec"}E). Nos and Pum are known to form a ternary complex with RNA, in which Nos stabilization depends on its interaction with both Pum and the RNA ([@bib37]). In light of these data, our results are consistent with the presence of CCR4, Pum, and Nos in the same complex and with the role of RNA in stabilizing Nos in the complex.

Taken together, these results indicate that CCR4, Pum, and Nos form a complex in the GSCs that is required for their self-renewal.

GSCs Lacking Both *twin* and *bam* Can Differentiate {#sec2.4}
----------------------------------------------------

Extensive analyses of *pum/bam* relationships have shown that *pum* is not involved in the repression of Bam expression in the GSCs ([@bib6]) and that GSCs double mutant for *pum* and *bam* can differentiate ([@bib6; @bib41]). These data led to the proposition that *bam* antagonizes *pum* function in the cystoblasts: Bam would relieve the translational repression of differentiation factors imposed by Pum/Nos in the GSCs, thus promoting differentiation.

We reasoned that if *twin* is involved together with *pum* in translational repression of mRNA targets in the GSCs, *twin/bam* relationships should be similar to *pum/bam* relationships. To test this, we analyzed Bam protein expression in *twin*^*DG24102*^ germaria and found that Bam was not overexpressed in *twin* mutant GSCs (0%, n = 35) ([Figures 4](#fig4){ref-type="fig"}A and 4B), as was the case in *pum* mutant GSCs ([@bib6]). We also verified the lack of Bam upregulation in *pum* and *nos* mutant GSCs (0%, n = 18 and n = 43, respectively) ([Figure S4](#app2){ref-type="sec"}A).

We then recorded the phenotype of *twin bam* double mutants. As reported for *pum bam* double mutants ([@bib6]), the *twin bam* phenotype was a mixture of both the *bam* phenotype (tumor of undifferentiated cells identified by the presence of a spectrosome; [Figure 4](#fig4){ref-type="fig"}C) and the *twin* phenotype (loss of GSCs). Similarly to *pum bam*, the *twin bam* phenotype evolved over time, with the percentage of *bam* phenotype decreasing and the percentage of *twin* phenotype increasing as the flies got older ([Figures 4](#fig4){ref-type="fig"}E and [S4](#app2){ref-type="sec"}B). Importantly, *twin bam* GSCs were able to differentiate, as shown by the presence of cysts with branched fusomes and older cysts containing cells with polyploid nuclei or ring canals ([Figures 4](#fig4){ref-type="fig"}D, [S4](#app2){ref-type="sec"}B, and S4C).

These results are consistent with *twin* and *pum* acting together in the repression of differentiation mRNAs in the GSCs for their self-renewal and with the role of *bam* in antagonizing *twin/pum* function for the differentiation in cystoblasts.

*mei-P26* mRNA Is a Target of Nos/Pum/CCR4 Regulation in GSCs {#sec2.5}
-------------------------------------------------------------

Mei-P26 is a potent differentiation factor in the GSC lineage. Strong *mei-P26* mutants develop ovarian tumors of cyst cells, and accordingly, Mei-P26 expression increases in -8-cell cysts and peaks in 16-cell cysts ([@bib26; @bib29]). However, Mei-P26 is already present in GSCs, although at lower levels, where it plays a role in self-renewal ([@bib23]). The tight regulation of Mei-P26 levels in the GSCs is essential, as overexpression of *mei-P26* in GSCs leads to their loss ([@bib29]) ([Figure S5](#app2){ref-type="sec"}). We addressed whether *mei-P26* regulation in the GSCs depended on the Nos/Pum/CCR4 complex. Because Pum is the specific RNA binding protein in the Nos/Pum complex, we used Pum immunoprecipitation (IP) experiments to investigate whether *mei-P26* mRNA was in complex with Pum in GSC-like cells. Using RT-PCR and qRT-PCR, we found an enrichment of *mei-P26* mRNA in Pum IP compared to in mock IP ([Figures 5](#fig5){ref-type="fig"}A and 5B). While CCR4 itself does not bind specifically to RNA, a specific interaction might be recorded between CCR4 and mRNAs resulting from the recruitment of CCR4 onto mRNAs by RNA binding proteins. We performed IP of CCR4-HA expressed with *nos-Gal4* in *bam*^*Δ86*^ mutant ovaries and found an enrichment of *mei-P26* mRNA in CCR4-HA IP compared to in mock IP ([Figures 5](#fig5){ref-type="fig"}A and 5B).

A potential poly(A) site has been mapped in *mei-P26* at position 844 after the stop codon in ovaries ([@bib26]) (cDNA clone GH10646 from FlyBase). However, a more recent study identified another *mei-P26* mRNA in ovaries with an extended 3′ UTR of about 4 kb ([@bib35]). We therefore used mRNA circularization to map *mei-P26* poly(A) sites in early stages of oogenesis (germarium to stage 8 dissected from newly eclosed females). We identified two poly(A) sites at positions 1207 \[poly(A) site 1\] and 4303 \[poly(A) site 2\], respectively ([Figures 5](#fig5){ref-type="fig"}C and [S6](#app2){ref-type="sec"}). This indicated the potential utilization of *mei-P26* alternative poly(A) sites in ovaries. We sought to determine whether a specific poly(A) site was preferentially used in the GSCs. In particular, poly(A) test assays (PAT assays) used to measure poly(A) tail lengths at the abovementioned three poly(A) sites indicated that poly(A) sites at positions 844 and 1207 were poorly used in early ovaries (see below). We quantified by qRT-PCR the ratio of mRNA upstream of position 844 to mRNA cleaved at poly(A) site 2 and compared this ratio between early ovarian stages containing mostly differentiated cells (germarium to stage 8) and GSC-like cells from *bam*^*Δ86*^ mutant ovaries. Using two different sets of primers upstream of position 844 (primers 1 and 2) and one set just upstream of poly(A) site 2 (primers 3) ([Figure 5](#fig5){ref-type="fig"}C), we found that the ratios (primers 1 or 2/primers 3) were strongly reduced in GSC-like cells, indicating the increased utilization of poly(A) site 2 in these cells ([Figure 5](#fig5){ref-type="fig"}D).

To investigate potential direct interactions between the Nos/Pum/CCR4 complex and *mei-P26* mRNA, we looked for Pum binding sites in *mei-P26* 3′ UTR. Two Pum binding sites have been defined: UGUAHAUA ([@bib12]) and the Nanos response element (NRE) GUUGN(3 to 45)AUUGUA, first identified in *hunchback* (*hb*) mRNA ([@bib7; @bib45]). Two UGUAHAUA Pum binding sites and one NRE are present in *mei-P26* 3′ UTR ([Figures 5](#fig5){ref-type="fig"}C and [S6](#app2){ref-type="sec"}). We used RNA pull-down assays with the C-terminal moiety of Pum, which contains the RNA binding domain (HA-PumC) synthesized in vitro, to identify potential fragments of *mei-P26* 3′ UTR that directly interacted with PumC. A region of *oskar* (*osk*) coding sequence, not known to be bound by Pum, and the region of *hb* 3′ UTR containing the NRE were used as negative and positive control RNAs, respectively. Surprisingly, none of the fragments containing a Pum binding motif in *mei-P26* 3′ UTR were able to strongly pull down PumC, although fragments containing the NRE appeared to weakly do so ([Figure 5](#fig5){ref-type="fig"}E). The 5′-most Pum binding motif was also shown recently to be inactive in *mei-P26* repression in male germ cell cysts ([@bib16]). However, we identified another fragment of *mei-P26* 3′ UTR (\#2) that was able to pull down PumC ([Figures 5](#fig5){ref-type="fig"}C and 5E). Competition assays were used to test the binding specificity of PumC to this fragment. Unlabeled *osk* or *hb* RNA fragments were added in excess (20× or 50×) to the binding reaction. The presence of *osk* RNA competitor had no effect on the binding of PumC to fragment \#2. In contrast, increasing amounts of *hb* NRE fragment increasingly reduced the pull down of PumC by fragment \#2, consistent with a specific binding of Pum to this region ([Figure 5](#fig5){ref-type="fig"}F). Although this fragment does not contain a canonical Pum binding site, it has a degenerated motif (UGUAACAA) that might be used to interact with Pum ([Figure S6](#app2){ref-type="sec"}).

We then measured poly(A) tail length variations of *mei-P26* mRNA in *twin* mutant early ovarian stages (germarium to stage 8) using PAT assays. Different primers were used to visualize potential poly(A) tails at position 844, poly(A) site 1, and poly(A) site 2. PAT assays in the region of position 844 and poly(A) site 1 did not produce the expected smear corresponding to different sizes of poly(A) tails, but did produce a discrete band ([Figure 5](#fig5){ref-type="fig"}G). This suggested a poor utilization of these poly(A) sites in early ovarian stages (although their usage was even weaker in GSC-like cells). In both cases, the discrete band would correspond to PCR amplification between the *mei-P26* primer and the poly(A) stretch present downstream of position 844 and poly(A) site 1 ([Figure S6](#app2){ref-type="sec"}), thus indicating an extended 3′ UTR. In contrast, PAT assays in the region of poly(A) site 2 produced the expected smear indicating the utilization of this poly(A) site ([Figure 5](#fig5){ref-type="fig"}G). The *mei-P26* poly(A) tails were longer in *twin*^*DG24102*^ mutant than in wild-type, consistent with the repression of *mei-P26* mRNA by CCR4-NOT-mediated deadenylation.

We next analyzed the effect of *mei-P26* mRNA deadenylation by measuring Mei-P26 protein levels in GSCs. As described above, Mei-P26 was present in GSCs and its amount increased in 16-cell cysts ([Figures 6](#fig6){ref-type="fig"}A and 6E). Mei-P26 levels were significantly increased in GSCs mutant for *twin*, *pum*, or *nos*, consistent with the translational repression of *mei-P26* mRNA by the Nos/Pum/CCR4 complex in GSCs ([Figures 6](#fig6){ref-type="fig"}A--6E). Increased levels of Mei-P26 in *twin* mutant GSCs were confirmed using the clonal analysis ([Figures 6](#fig6){ref-type="fig"}F and 6G).

Together, these results show that *mei-P26* mRNA is a direct target of the Nos/Pum/CCR4 complex through its interaction with Pum protein. Binding of the complex to *mei-P26* mRNA leads to deadenylation and translational repression, resulting in the fine-tuning of Mei-P26 protein levels in the GSCs.

*mei-P26* mRNA Is a Major Target of CCR4 for GSC Self-Renewal {#sec2.6}
-------------------------------------------------------------

We addressed whether this regulation of *mei-P26* mRNA by Nos/Pum/CCR4 was functionally important by determining the effect of reducing *mei-P26* gene dosage in *twin* mutant ovaries. Strikingly, reduction of one copy of *mei-P26* gene strongly rescued the *twin*^*DG24102*^ phenotype of GSC loss and resulted in normal egg chamber development ([Figures 6](#fig6){ref-type="fig"}H--6J). About 60% of germaria contained GSCs in *mei-P26*^*−/+*^*; twin*^*DG24102*^ 21-day-old-females compared to 0% in *twin*^*DG24102*^ females of the same age ([Figure 6](#fig6){ref-type="fig"}J). This shows that *mei-P26* mRNA is an essential target of CCR4 for GSC self-renewal. Although *mei-P26* is unlikely to be the only target of CCR4-mediated regulation in GSCs, its control by CCR4 has a major impact in GSC self-renewal, possibly because of its central role in GSC biology.

Discussion {#sec3}
==========

Here, we have provided evidence that the *twin* gene that encodes the CCR4 deadenylase is essential for GSC self-renewal. GSCs are rapidly lost in *twin* mutants because they differentiate and cannot self-renew. Clonal analysis shows that *twin* is required cell autonomously in the GSCs for their self-renewal. Nos and Pum are major factors of GSC self-renewal and are translational repressors ([@bib13; @bib44]). Genetic and protein interactions among *twin*, *nos*, and *pum* indicate that CCR4 acts together with Nos and Pum to promote GSC self-renewal. This identifies the recruitment of the CCR4-NOT deadenylation complex as the molecular mechanism underlying Nos and Pum translational repression in the GSCs. Two mechanisms of action used by Nos/Pum have previously been described in the embryo. First, Nos/Pum represses *hb* mRNA translation by forming a complex with Brat, which in turn interacts with 4EHP and blocks initiation of translation ([@bib8; @bib38]). Second, Nos/Pum represses *cyclin B* mRNA translation in the primordial germ cells by recruiting the CCR4-NOT complex through direct interactions between Pum and CAF1 and between Nos and NOT4 ([@bib20]). Brat is not expressed in GSCs ([@bib15]), thus excluding the first mode of Nos/Pum translational repression in these cells. However, we did find Pum, Nos, and CCR4 present in a complex in GSC-like cells, consistent with the recruitment of the CCR4-NOT complex by Nos/Pum for GSC self-renewal.

Interestingly, a mutant form of CCR4 that is inactive for deadenylation is able to partially rescue the lack of CCR4 in GSCs. This is consistent with CCR4 not being the only deadenylase in the complex ([@bib43]). However, CCR4 does participate in the deadenylation activity of the complex, probably via a structural role. Furthermore, the CCR4-NOT complex has been shown recently to be involved in direct translational repression, in addition to its role in deadenylation ([@bib5; @bib9]). This dual mode of action of CCR4-NOT might also be relevant to GSCs.

The miRNA pathway also plays a crucial role in GSC self-renewal ([@bib18; @bib31; @bib49]). A large body of evidence has shown that an important mechanism of silencing by miRNAs involves deadenylation resulting from the recruitment of CCR4-NOT by GW182 bound to Ago1 (for review, see [@bib3]). Therefore, the CCR4-NOT complex is also likely to contribute to miRNA-mediated translational repression in the GSCs, thus making this complex a central effector of translational repression in the GSCs.

An important result from this study is that *mei-P26* mRNA is a major target of Nos/Pum/CCR4 regulation for GSC self-renewal ([Figure 7](#fig7){ref-type="fig"}). Nos and Pum are known to be essential players in GSC self-renewal, and many mRNAs are expected to be regulated by this complex. However, to date only one mRNA target of this complex, *brat*, has been reported. Here, we have identified another target, *mei-P26* mRNA, and have shown that its repression by the Nos/Pum/CCR4 complex has a key role in GSC self-renewal, because the loss of GSCs in the *twin* mutant is strongly rescued by decreasing *mei-P26* gene dosage.

Both Brat and Mei-P26 belong to the Trim-NHL family of proteins, which have conserved functions in stem cell lineages from *C. elegans* to mouse (for review, see [@bib46]). Proteins within this family are potential E3 ubiquitin ligases and can act by either activating or antagonizing the miRNA pathway, through their association with Ago1 and GW182. In particular, Mei-P26 function switches from activation of the miRNA pathway in the GSCs ([@bib23]) to inhibition of the pathway in differentiating cysts where Mei-P26 levels are higher ([@bib29]). As such, Mei-P26 plays a central role in the control of cell fate in the GSC lineage. The rescue of the *twin* mutant phenotype of GSC loss by decreasing *mei-P26* gene dosage suggests that the levels of Mei-P26 themselves might be important for this switch of its function. This might provide an explanation as to why such a precise regulation of its level is crucial for GSC self-renewal and differentiation.

Which molecular mechanisms underlie the fine-tuning of Mei-P26 in the GSC lineage? The translational repression of *mei-P26* mRNA is not complete in GSCs. This differs from the complete repression by Nos/Pum of *cyclin B* mRNA in the primordial germ cells, or *brat* mRNA in the GSCs, and may result from the concomitant activation of *mei-P26* by Vasa ([@bib26]). Vasa does activate *mei-P26* translation, leading to a peak of expression in -8- and 16-cell cysts. However, Vasa is expressed in all germ cells, suggesting that it is not the key regulator governing the timing of Mei-P26 peak of expression. We propose that translational activation of Mei-P26 by Vasa would be active already in GSCs but counterbalanced by translational repression by Nos/Pum and the CCR4-NOT complex ([Figure 7](#fig7){ref-type="fig"}). In cystoblasts, the presence of Bam overcomes Nos/Pum translational repression by decreasing Nos levels ([@bib22]), which would thus switch the balance to translational activation by Vasa. This does not lead to a peak of Mei-P26 expression in cystoblasts, but rather to a progressive increase of Mei-P26 levels in proliferating cysts. This progressive accumulation of Mei-P26 could depend on the necessity to build up Vasa-mediated translational activation. However, another possibility could be that a different factor still partially represses *mei-P26* translation in cystoblasts and early cysts. A potential candidate is Bam, which has been defined as a translational repressor ([@bib22; @bib34]) and has recently been reported to directly repress *mei-P26* mRNA translation in the male GSC lineage ([@bib16]). The Bam expression profile in female germ cells is consistent with this potential role in *mei-P26* translational repression, because Bam protein is present from cystoblasts to 8-cell cysts but absent in 16-cell cysts, where Mei-P26 levels are the highest ([@bib22]).

Recent advances have established the generality of a central role for translational regulations in adult stem cell lineages ([@bib10; @bib15; @bib16]). Translational repression is required to prevent the synthesis of differentiation factors whose mRNAs are already present in stem cells. In the *Drosophila* female GSC lineage, recent work has demonstrated that changes in cell fate are driven by different translational regulation programs; associations between translational repressors evolve to trigger stage-specific regulation of mRNA targets. For example, while Nos/Pum maintain female GSCs by repressing a specific set of mRNAs, Pum associates with Brat in cystoblasts to repress a different set ([@bib15]). The Trim-NHL proteins appear to be of particular importance in the translational regulations essential for stem cell fate as exemplified by Mei-P26 ([@bib23; @bib24; @bib29]). Here, we add that the fine-tuning of Mei-P26 protein levels by translational repression is essential for GSC self-renewal and implicate CCR4 in this regulation.

The functions of Trim-NHL proteins are conserved in many adult stem cell lineages in different organisms, and mutations in the corresponding genes lead to highly proliferative tumors. Elucidating the molecular mechanisms behind their translational control is key to deciphering how these proteins regulate adult stem cell fates.

Experimental Procedures {#sec4}
=======================

*Drosophila* stocks are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

DNA Constructs {#sec4.1}
--------------

The DNA encoding the deadenylase-dead form of CCR4 ([@bib43]) was cloned into the *pUASP* vector digested with KpnI and *XbaI*. In this mutant form of CCR4, amino acids 412 (aspartic acid) and 414 (asparagine) were substituted by alanine. Transgenic stocks were generated by BestGene. The HA-PumC construct was obtained by inserting the 2,236 pb SmaI to *Xba*I fragment from the pGEX-PumC ([@bib51]) (animo acids 849--1,533) into the *Stu*I and *Xba*I sites of the pCSH3 (pCS2+ backbone vector with two HA tags).

Antibodies and Immunostaining {#sec4.2}
-----------------------------

The rabbit and guinea pig anti-Pum antibodies were raised by Agro-Bio against amino acids 408--883 of the Pum protein ([@bib51]). Antibody dilutions for immunostaining and fluorescence quantification are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Immunoprecipitations and RNA Pull-Down Assays {#sec4.3}
---------------------------------------------

The procedures for immunoprecipitations and RNA pull-down assays are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

RNA Circularization {#sec4.4}
-------------------

RNA circularization was performed as previously described ([@bib4]), with RT-PCR reactions followed by nested PCR. The primers used are listed in [Table S1](#app2){ref-type="sec"}.

PAT Assays, RT-PCR, and qRT-PCR {#sec4.5}
-------------------------------

PAT assays, RT-PCR, and qRT-PCR were performed as described previously using two to four independent RNA preparations ([@bib19; @bib50]), and the ePAT method of PAT assays was also used ([@bib17]). The primers used are listed in [Table S1](#app2){ref-type="sec"}. Quantitative PCR experiments were performed with the LightCycler System (Roche Molecular Biochemical).

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S6, and Table S1
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![CCR4 Is Expressed in the GSCs and Is Required for Their Self-Renewal\
(A) Schematic representation of a germarium. GSC, germline stem cell; CB, cystoblast; TF, terminal filament, CC, cap cell; and FSC, follicle stem cell.\
(B) Schematic representation of the *twin* locus, *twin*^*DG24102*^*, twin*^*41*^, and *twin*^*8115*^ mutants. Black boxes indicate exons. The arrow indicates the transcription start site. The *P-Hobo* (*yHw*) transposable element (not drawn to scale) inserted in *twin*^*DG24102*^ is shown. The coordinates of the insertion sites are 20027036 for *twin*^*DG24102*^ and 20032277 for *twin*^*8115*^, according to the AE014297 sequence in NCBI.\
(C--D′) Expression of CCR4 in GSCs. Wild-type (C and C′) and *twin*^*DG24102*^ mutant (D and D′) germaria labeled with anti-CCR4 antibody (red) and 1B1 (green), which marks the spectrosome and fusome. The merge is shown in C′ and D′. Right panels show higher magnifications of the anterior tips of germaria shown in the left panels. White arrows indicate GSCs.\
(E--G) *twin* mutant phenotype of loss of GSCs. Wild-type (E) and *twin*^*DG24102*^ (F and G) mutant germaria labeled with 1B1 (green) and anti-Vasa antibody (red). Vasa is used as a germ cell marker. White arrows indicate GSCs. (F) Lack of GSCs and the presence of a differentiating cyst. (G) Lack of GSCs and germ cells. Scale bars represent 20 μm in (C--G).\
(H) Quantification of germaria containing at least one GSC in different *twin* mutant and control genotypes in 3-, 7-, 14-, and 21-day-old females. n represents the number of germaria scored.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![*twin* Is Cell-Autonomously Required in GSC Self-Renewal\
(A) Clonal *twin* mutant GSCs do not self-renew. Control (top panel) and *twin*^*DG24102*^ (bottom panel) mosaic germaria labeled with GFP (green) and 1B1 (red) 7 days after clone induction. Clonal cells, marked by the lack of GFP, are outlined with white dotted lines.\
(B) Quantification of germaria containing at least one clonal GSC 3, 7, 14, and 21 days after clone induction (n = 111 to 497 germaria).\
(C--E) Rescue of *twin* mutant phenotype of GSC loss with CCR4 expression in germ cells. Wild-type (C); *twin*^*DG24102*^, *nos-Gal4*/*twin*^*DG24102*^ (D); *twin*^*DG24102*^, *nos*-*Gal4*/*twin*^*DG24102*^, *UASp-CCR4-HA* (E) labeled with 1B1 (green) and anti-Vasa (red). White arrows indicate GSCs. Scale bars represent 20 μm in (A) and (C--E).\
(F) Quantification of germaria containing at least one GSC in *twin* mutant and rescued contexts, in 3-, 7-, 14-, and 21-day-old females. n represents the number of germaria scored.\
See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![*twin* Genetically and Physically Interacts with *nos* and *pum* in GSCs\
(A) Quantification of germaria containing at least one GSC in *twin* mutant 3- and 7-day-old females, in combination or not with *pum* or *nos* heterozygous mutants. n represents the number of germaria scored.\
(B) Coimmunoprecipitations with CCR4-HA in GSC-like cells. Ovarian extracts from *bam*^*Δ86*^ and *bam*^*Δ86*^, *nos-Gal4/bam*^*Δ86*^, *UASp-CCR4-HA* flies were immunoprecipitated with anti-HA, either in the absence or the presence (right panel, RNase) of RNase A. Western blots were revealed with anti-CCR4, anti-Pum, and anti-Nos antibodies.\
(C) Coimmunoprecipitations with Pum in GSC-like cells. Ovarian extracts from *bam*^*Δ86*^ flies were immunoprecipitated with anti-Pum (Pum IP) or mock immunoprecipitated (Mock IP), either in the absence or the presence (RNase) of RNase A. Western blots were revealed with anti-Pum, anti-CCR4, and anti-Nos antibodies. The asterisk marks a nonspecific band recognized by the anti-Pum antibody in the input. Input is the protein extract (1/25) prior to immunoprecipitation in (B) and (C).\
See also [Figure S3](#app2){ref-type="sec"}.](gr3){#fig3}

![*twin* Function Is Epistatic to *bam*\
(A and B) Bam levels are not upregulated in *twin* mutant GSCs. Wild-type (A) and *twin*^*DG24102*^ (B) germaria labeled with anti-Bam antibody (green). The merges between anti-Bam (green), DAPI (blue), and 1B1 (red) are shown in (A′) and (B′). White arrows indicate GSCs.\
(C and D) *twin bam* double mutant GSCs can differentiate. *bam*^*Δ86*^ (C and C′) and *Df(3R)Exel6198*, *bam*^*Δ86*^*/twin*^*41*^, *bam*^*Δ86*^ (D and D′) germaria labeled with 1B1 (green) and anti-Vasa (red). A differentiated cyst marked by the presence of a branched fusome is outlined with a white dotted line. Scale bars represent 20 μm in (A--D).\
(E) Quantification of germaria, labeled with 1B1 and anti-Vasa, presenting a *bam*-like phenotype (accumulation of GSC-like cells containing a spectrosome), a mixed phenotype (presence of GSC-like cells and of differentiating cysts, e.g., in D), or a *twin*-like phenotype (lack of GSCs or lack of germ cells) in *Df(3R)Exel6198*, *bam*^*Δ86*^*/twin*^*41*^, *bam*^*Δ86*^ double mutant germaria in 3-, 7-, 14-, and 21-day-old females. n represents the number of germaria scored.\
See also [Figure S4](#app2){ref-type="sec"}.](gr4){#fig4}

![*mei-P26* mRNA Is a Target of the Nos/Pum/CCR4 Complex in the GSCs\
(A and B) RNA immunoprecipitations (IP) with the anti-Pum antibody in *bam*^*Δ86*^ ovarian extracts (left panels, Mock IP: preimmune serum) and with the anti-HA antibody in *bam*^*Δ86*^ and *nos-Gal4*, *bam*^*Δ86*^*/UASp-CCR4-HA*, *bam*^*Δ86*^ (*bam*^*Δ86*^*, CCR4-HA*) ovarian extracts (right panels). *sop* mRNA was used as a negative control. (A) Top panels show protein IP using western blots (WB). Bottom panels show the enrichment of *mei-P26* mRNA in IP compared to in mock IP, visualized by RT-PCR. Inputs are protein or RNA extracts (1/10) prior to immunoprecipitation. Two (HA IP) and four (Pum IP) IPs were performed with similar results. (B) Quantification by qRT-PCR. Normalization was with *sop* mRNA. Quantifications were done in triplicate, and error bars represent SD. ^∗∗∗∗^p \< 0.0001 using the t test.\
(C) Schematic representation of *mei-P26* 3′ UTR showing position 844, the two poly(A) sites identified by RNA circularization and the three potential Pum binding motifs, including the NRE-type motif. RNA fragments tested in RNA pull-down assays (\#1 to \#6) and primer sets (1, 2, and 3) used to quantify the utilization of alternative poly(A) sites are also indicated. Coordinates are from the STOP codon, 1 being the first nucleotide of the 3′ UTR (see also [Figure S6](#app2){ref-type="sec"}).\
(D) Quantification by qRT-PCR of ratios of mRNA levels upstream of position 844 to just upstream of poly(A) site 2, in wild-type early ovarian stages and *bam*^*Δ86*^ mutant ovaries. Two primer sets (1 and 2) localized upstream of position 844 gave similar results. Means are from two independent RNA extracts quantified in triplicate, and error bars represent SD. ^∗∗∗^p \< 0.0005 using the t test.\
(E) RNA pull-down assays using the *mei-P26* RNA fragments \#1 to \#6 shown in (C) and HA-PumC protein. Input is the in vitro synthesized protein (1/10) prior to RNA pull-down. *osk* and *hb* RNA fragments are negative and positive controls for Pum-C binding, respectively.\
(F) RNA pull-down competition assays of *mei-P26* RNA fragment \#2 with increasing amounts of *osk* or *hb* unlabeled RNA fragments. Lane 2 is HA-PumC pull-down with fragment \#2 in the absence of competitor. Input is as in (E).\
(G) PAT assays of *mei-P26* mRNA with specific primers allowing to measure potential poly(A) tails downstream of position 844 and poly(A) site 1 (left panel), and poly(A) site 2 (right panel), in wild-type and *twin*^*DG24102*^ early ovarian stages. *sop* was used as a control mRNA. PAT assay profiles of *mei-P26* poly(A) site 2, using ImageJ, are shown.](gr5){#fig5}

![*mei*-*P26* Is a Major Target of CCR4-Mediated Translational Repression for GSC Self-Renewal\
(A--D) Upregulation of Mei-P26 protein levels in *twin*, *pum*, and *nos* mutant GSCs. Wild-type (A), *twin*^*DG24102*^ (B), *pum*^*MSC*^*/pum*^*01688*^ (C), and *nos*^*18*^*/nos*^*53*^ (D) germaria from 3-day-old females stained with anti-Mei-P26 antibody (green). The merges between anti-Mei-P26 (green) and 1B1 (red) are shown in (A′--D′). White arrows indicate GSCs. Scale bars represent 10 μm.\
(E) Quantification of fluorescence intensity ratios between GSCs and cysts in the four genotypes shown in (A--D). The numbers of germaria used in the quantification were 44 wild-type, 22 *twin*^*DG24102*^, 24 *pum*^*MSC*^*/pum*^*01688*^, and 14 *nos*^*18*^*/nos*^*53*^. Error bars represent SD. ^∗^p = 0.01, ^∗∗∗^p = 0.0007, and ^∗∗∗∗^p \< 0.0001 using the t test.\
(F and G) Upregulation of Mei-P26 protein levels in *twin* mutant clonal GSCs. (F) Example of *twin*^*DG24102*^ mosaic germarium labeled with GFP (green), 1B1 (purple), and anti-Mei-P26 (red) 7 days after clone induction. The white arrow indicates the *twin*^*DG24102*^ clonal GSC (lack of GFP) and the white arrowhead indicates the *twin*^*DG24102*^*/+* heterozygous GSC. Scale bars represent 10 μm. (G) Quantification of fluorescence intensity of Mei-P26 staining in *twin*^*DG24102*^*/+* heterozygous and *twin*^*DG24102*^ clonal GSCs. n = 8 germaria. Bars represent means with SD. ^∗∗^p = 0.0088 using the t test.\
(H and I) Rescue of *twin*^*DG24102*^ mutant phenotype of GSC loss by decreasing the gene dosage of *mei-P26*. *twin*^*DG24102*^ (H and H′) and *mei-P26*^*fs1*^*/+; twin*^*DG24102*^ (I and I′) ovaries labeled with 1B1 (green) and anti-Vasa (red) in 7-day-old females. (I) The white arrows indicate GSCs; oogenesis appears normal. Scale bars represent 20 μm in (H) and 60 μm in (I).\
(J) Quantification of germaria containing at least one GSC in *twin*^*DG24102*^, *mei-P26*^*fs1*^*/+; twin*^*DG24102*^ and *mei-P26*^*mfs1*^*/+; twin*^*DG24102*^ mutant females of 3, 7, 14 and 21 days. n represents the number of germaria scored.](gr6){#fig6}

![Model for the Role of CCR4 in GSC Self-Renewal\
In the GSCs, the CCR4-NOT deadenylation complex interacts with Nos and Pum and is recruited to *mei-P26* mRNA to repress its translation. Translational repression is counterbalanced by Vasa-mediated translational activation, leading to low levels of Mei-P26 protein, which cooperate with the miRNA pathway for silencing of mRNAs encoding differentiation factors. The CCR4-NOT complex is also likely to participate in miRNA silencing through its recruitment by GW182, as it is the case in other cell types. In cystoblasts, Bam represses *nos* mRNA translation (possibly together with Bgcn, Sex-Lethal, and Mei-P26; [@bib24]), resulting in the new association of Pum with Brat to target a different set of mRNAs ([@bib15]). Mei-P26 levels do not increase, potentially due to a different mechanism of translational repression that might involve Bam. In eight-cell and 16-cell cysts, translational repression of *mei-P26* mRNA is relieved, leading to an increase of Mei-P26 levels that antagonize miRNA-dependent silencing of mRNAs encoding differentiation factors.](gr7){#fig7}
